| Literature DB >> 28265064 |
Yu Shrike Zhang1,2,3, Julio Aleman4,2,5, Su Ryon Shin4,2,3, Tugba Kilic4,2,6, Duckjin Kim4,2, Seyed Ali Mousavi Shaegh4,2,7, Solange Massa4,2,8, Reza Riahi4,2, Sukyoung Chae4,2, Ning Hu4,2,9, Huseyin Avci4,2,10, Weijia Zhang4,2,11, Antonia Silvestri4,2,12, Amir Sanati Nezhad4,2,13, Ahmad Manbohi4,2,14, Fabio De Ferrari4,2,12, Alessandro Polini4,2, Giovanni Calzone4,2, Noor Shaikh4,2,15, Parissa Alerasool4,2, Erica Budina4,2, Jian Kang4,2, Nupura Bhise4,2, João Ribas4,2,16, Adel Pourmand4,2,17, Aleksander Skardal5, Thomas Shupe5, Colin E Bishop5, Mehmet Remzi Dokmeci4,2,3, Anthony Atala5, Ali Khademhosseini1,2,3,18,19.
Abstract
Organ-on-a-chip systems are miniaturized microfluidic 3D human tissue and organ models designed to recapitulate the important biological and physiological parameters of their in vivo counterparts. They have recently emerged as a viable platform for personalized medicine and drug screening. These in vitro models, featuring biomimetic compositions, architectures, and functions, are expected to replace the conventional planar, static cell cultures and bridge the gap between the currently used preclinical animal models and the human body. Multiple organoid models may be further connected together through the microfluidics in a similar manner in which they are arranged in vivo, providing the capability to analyze multiorgan interactions. Although a wide variety of human organ-on-a-chip models have been created, there are limited efforts on the integration of multisensor systems. However, in situ continual measuring is critical in precise assessment of the microenvironment parameters and the dynamic responses of the organs to pharmaceutical compounds over extended periods of time. In addition, automated and noninvasive capability is strongly desired for long-term monitoring. Here, we report a fully integrated modular physical, biochemical, and optical sensing platform through a fluidics-routing breadboard, which operates organ-on-a-chip units in a continual, dynamic, and automated manner. We believe that this platform technology has paved a potential avenue to promote the performance of current organ-on-a-chip models in drug screening by integrating a multitude of real-time sensors to achieve automated in situ monitoring of biophysical and biochemical parameters.Entities:
Keywords: drug screening; electrochemical biosensor; microbioreactor; organ-on-a-chip; physical sensor
Mesh:
Year: 2017 PMID: 28265064 PMCID: PMC5373350 DOI: 10.1073/pnas.1612906114
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205